These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29141973)

  • 21. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prader-Willi syndrome: relationship of adiposity to plasma leptin levels.
    Pietrobelli A; Allison DB; Faith MS; Beccaria L; Bosio L; Chiumello G; Campfield LA; Heymsfield SB
    Obes Res; 1998 May; 6(3):196-201. PubMed ID: 9618123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.
    Erhardt É; Molnár D
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
    Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
    Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome.
    Davies PS; Joughin C
    Am J Ment Retard; 1993 Nov; 98(3):349-53. PubMed ID: 8292311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gait strategy and body composition in patients with Prader-Willi syndrome.
    Cimolin V; Cau N; Galli M; Pau M; Parisio C; Saezza A; Grugni G; Capodaglio P
    Eat Weight Disord; 2021 Feb; 26(1):115-124. PubMed ID: 31797332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a measurement system for assessment of energy expenditure and physical activity in Prader-Willi syndrome.
    Chen KY; Sun M; Butler MG; Thompson T; Carlson MG
    Obes Res; 1999 Jul; 7(4):387-94. PubMed ID: 10440595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total daily energy expenditure in wasted chronic obstructive pulmonary disease patients.
    Tang NL; Chung ML; Elia M; Hui E; Lum CM; Luk JK; Jones MG; Woo J
    Eur J Clin Nutr; 2002 Apr; 56(4):282-7. PubMed ID: 11965503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative Contributions of Lean and Fat Mass to Bone Mineral Density: Insight From Prader-Willi Syndrome.
    Viardot A; Purtell L; Nguyen TV; Campbell LV
    Front Endocrinol (Lausanne); 2018; 9():480. PubMed ID: 30186239
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of obesity onset on pendular energy transduction at spontaneous walking speed: Prader-Willi versus nonsyndromal obese individuals.
    Malatesta D; Vismara L; Menegoni F; Grugni G; Capodaglio P
    Obesity (Silver Spring); 2013 Dec; 21(12):E586-91. PubMed ID: 23554340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RESTING METABOLIC RATE IN PRADER-WILLI SYNDROME.
    Hill JO; Kaler M; Spetalnick B; Reed G; Butler MG
    Dysmorphol Clin Genet; 1990; 4(1):27-32. PubMed ID: 27570368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energy expenditure and body composition in Prader-Willi syndrome.
    Schoeller DA; Levitsky LL; Bandini LG; Dietz WW; Walczak A
    Metabolism; 1988 Feb; 37(2):115-20. PubMed ID: 3340003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.
    Schmidt H; Pozza SB; Bonfig W; Schwarz HP; Dokoupil K
    J Pediatr Endocrinol Metab; 2008 Jul; 21(7):651-5. PubMed ID: 18780599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
    Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
    Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in Energy Expenditure with Weight Gain and Weight Loss in Humans.
    Müller MJ; Enderle J; Bosy-Westphal A
    Curr Obes Rep; 2016 Dec; 5(4):413-423. PubMed ID: 27739007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The associations between diet and physical activity with body composition and walking a timed distance in adults with Prader-Willi syndrome.
    Woods SG; Knehans A; Arnold S; Dionne C; Hoffman L; Turner P; Baldwin J
    Food Nutr Res; 2018; 62():. PubMed ID: 29942245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical activity and maximal oxygen uptake in adults with Prader-Willi syndrome.
    Gross I; Hirsch HJ; Constantini N; Nice S; Pollak Y; Genstil L; Eldar-Geva T; Tsur VG
    Eat Weight Disord; 2018 Oct; 23(5):615-620. PubMed ID: 28299717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary intake in youth with prader-willi syndrome.
    Mackenzie ML; Triador L; Gill JK; Pakseresht M; Mager D; Field CJ; Haqq AM
    Am J Med Genet A; 2018 Nov; 176(11):2309-2317. PubMed ID: 30216657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.